GGrantIndex
← Search

Biostatistics (BSR)

$59,219P30FY2017CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications, trials & patents

Paper 39684445Paper 39678719Paper 39605468Paper 39580490Paper 39573886Paper 39456534Paper 39450301Paper 39436320Paper 39420209Paper 39386613Paper 39386448Paper 39384153Paper 39339419Paper 39224072Paper 39219576Paper 39151112Paper 39141488Paper 39130636Paper 39125017Paper 39110778Paper 39107463Paper 39080401Paper 39013847Paper 38974465Paper 38969056Paper 38946943Paper 38900505Paper 38853862Paper 38847506Paper 38775157Paper 38770637Paper 38733583Paper 38712184Paper 38704607Paper 38687198Paper 38683788Paper 38672426Paper 38617282Paper 38603627Paper 38547055Paper 38542184Paper 38514303Paper 38482976Paper 38445903Paper 38437585Paper 38429478Trial NCT03226418Trial NCT03073785Trial NCT02874404Trial NCT02833701Trial NCT02654119Trial NCT02561273Trial NCT02553447Trial NCT02168270Trial NCT01959672Trial NCT01825603Trial NCT01750073Trial NCT01555632Trial NCT01431209Trial NCT01336933Trial NCT01336920Trial NCT01307956Trial NCT01106898Trial NCT01093183Trial NCT01068327Trial NCT01044745Trial NCT01035463Trial NCT00959244Trial NCT00856037Trial NCT00816413Trial NCT00736450Trial NCT00679029Trial NCT00666731Trial NCT00665457Trial NCT00625690Trial NCT00617799Trial NCT00611351Trial NCT00607828Trial NCT00602797Trial NCT00577798Trial NCT00569543Trial NCT00503880Trial NCT00499083Trial NCT00496756Trial NCT00486356Trial NCT00483561Trial NCT00483366Trial NCT00482807Trial NCT00089024Trial NCT00082641Trial NCT00007865Trial NCT00007852Trial NCT00006478Trial NCT00004874Trial NCT00004198Trial NCT00004197Trial NCT00004192Trial NCT00004112Patent 7166704Patent 6680196

Abstract

Project Summary/Abstract: Biostatistics Shared Resource (BSR) The goal of the Biostatistics Shared Resource (BSR) of the Cancer Center is to participate in the research mission of the institution by making the expertise and experience of its personnel available to Cancer Center members for planning, conducting, and reporting of basic, translational, clinical, and population-based research projects. The overarching goal of the Biostatistics Shared Resource is to ensure the highest quality biostatistical and scientific standards for the Cancer Center. The Co-Directors of the BSR are Drs. Meza and Haynatzki. Dr. Meza has collaborated with the Cancer Center since joining UNMC in 2000. In 2008, she became Co-Director of the Biostatistics Shared Resource. Dr. Meza is also Director of the Biostatistics Core for the Cancer Center`s Specialized Program of Research Excellence (SPORE) in pancreatic cancer. Dr. Haynatzki became a Co-Director with Dr. Meza shortly after he joined UNMC in 2008. The BSR plays a major role in the Cancer Center's scientific review committee and data safety committee for approving and monitoring clinical protocols. The BSR faculty members are active collaborators on numerous NCI-funded projects with Cancer Center members. The Biostatistics Shared Resource supports the infrastructure that facilitates the biostatistician's role in research conducted by Cancer Center investigators. With the CCSG, members of the BSR are a part of the administrative and bioinformatics infrastructure of the Cancer Center, providing input in planning, development, and operations. The CCSG allows Cancer Center investigators access to the expertise of the Biostatistics Shared Resource members for study design, grant development, protocol monitoring, and data analysis. CCSG support also allows the Biostatistics Shared Resource to attain a high level of recognition within the Cancer Center, and this has led to additional collaborations beyond the Cancer Center. With the continued commitment of the Cancer Center and UNMC to build resources for clinical and translational science faculty, use of the Biostatistics Shared Resource is expected to increase. These efforts will require biostatistical support for protocol and grant development, in addition to analysis and reporting of research results. The resources attained through the CCSG enhance collaborations that will continue to increase clinical research and peer-reviewed funding.

View original record on NIH RePORTER →